Intervention strategies for seasonal and emerging respiratory viruses with drugs and vaccines targeting viral surface glycoproteins

Ralph A. Tripp, John Stambas

Research output: Contribution to journalReview articlepeer-review

3 Citations (Scopus)

Abstract

Vaccines and therapeutics targeting viral surface glycoproteins are a major component of disease prevention for respiratory viral diseases. Over the years, vaccines have proven to be the most successful intervention for preventing disease. Technological advances in vaccine platforms that focus on viral surface glycoproteins have provided solutions for current and emerging pathogens like SARS-CoV-2, and our understanding of the structural basis for antibody neutralization is guiding the selection of other vaccine targets for respiratory viruses like RSV. This review discusses the role of viral surface glycoproteins in disease intervention approaches.

Original languageEnglish
Article number625
Pages (from-to)1-8
Number of pages8
JournalViruses
Volume13
Issue number4
DOIs
Publication statusPublished - Apr 2021
Externally publishedYes

Fingerprint

Dive into the research topics of 'Intervention strategies for seasonal and emerging respiratory viruses with drugs and vaccines targeting viral surface glycoproteins'. Together they form a unique fingerprint.

Cite this